Videum
 
 
pharmaphorum
pharmaphorum

pharmaphorum

Videos from pharmaphorum media, bringing healthcare together

0 Followers
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success   This video is intended for healthcare professionals only.
Register as a healthcare professional.

Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success  

Gary Hendler, chairman and CEO of EMEA region for Eisai, talked to Richard Staines at pharmaphorum about findings of the REFLECT study and the prospects for Lenvima (lenvatinib) in liver cancer.

Share
5

Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success

Gary Hendler, chairman and CEO of EMEA region for Eisai, talked to Richard Staines at pharmaphorum about findings of the REFLECT study and the prospects for Lenvima (lenvatinib) in liver cancer.

Duration: 04:33
Licence: CC - Attribution
Original Language: English
Published: 6/26/2018
Diseases and Conditions: Liver Cancer
Format: Interviews / KOL

Other videos in this channel

 

Related Videos

Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success

You cannot send your comments